Walter M,Wetterauer C,Bruder E,et al.Renal cell carcinoma in a young adult—Do we need further investigations[J].Urol Case Rep,2016,12(6):27-29.
[2]
Peotter JL,Phillips J,Tong T,et al.Involvement of Tiam1,RhoG and ELMO2/ILK in Rac1-mediated phagocytosis in human trabecular meshwork cells[J].Exp Cell Res,2016,347(2):301-311.
[3]
Zheng C,Diaz-Cuadros M,Chalfie M.GEFs and Rac GTPases control directional specificity of neurite extension along the anterior-posterior axis[J].Proc Natl Acad Sci USA,2016,113(25):6 973-6 978.
[4]
Niebel B,Wosnitza CI,Famulok M,et al.RNAaptamers that modulate the RhoGEF activity of Tiam1[J].Bioorg Med Chem,2013,21(20):6 239-6 246.
[5]
Seo AN,Yoon G,Ro JY.Clinicopathologic and molecular pathology of collecting duct carcinoma and related renal cell carcinomas[J].Adv Anat Pathol,2017,24(2):65-77.
[6]
Wallin U,Rothenberger D,Lowry A,et al.CEA-a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer[J].Dis Colon Rectum,2013,56(7):859-868.
[7]
Bhatt JR,Jewett MA,Richard PO,et al.Multilocular cystic renal cell carcinoma:pathological T staging makes no difference to favorable outcomes and should be reclassified[J].J Urol,2016,196(5):1 350-1 355.
[8]
Habets GG,Scholtes EH,Zuydgeest D,et al.Collard JG.Identification of an invasion-inducing gene,Tiam-1,that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins[J].Cell,1994,77(4):537-549.
[9]
Kuroda N,Yorita K,Nagasaki M,et al.Review of succinate dehydrogenase-deficient renal cell carcinoma with focus on clinical and pathobiological aspects[J].Pol J Pathol,2016,67:3-7.
[10]
Zhao G,Na R,Li L,et al.Vasohibin-1inhibits angiogenesis and suppresses tumor growth in renal cell carcinoma[J].Oncol Rep,2017,38(2):1 021-1 028.
[11]
Abdel-Mottaleb MM,Beduneau A,Pellequer Y,et al.Stability of fluorescent labels in PLGA polymeric nanoparticles:Quantum dots versusorganic dyes[J].Int J Pharm,2015,494(1):471-478.
[12]
Abraham GP,Cherian T,Mahadevan P,et al.Detailed study of survival of patients with renal cell carcinoma in India[J].Indian J Cancer,2016,53(4):572-574.
[13]
Buraczewska A,Kardas J.Axitinib in metastatic renal cell carcinoma:single center experience[J].Contemp Oncol(Pozn),2016,20(6):481-485.
[14]
Tan X,Li Y,Li X,et al.Electrochemical synthesis of small-sized red fluorescent graphene quantum dots as a bioimaging platform[J].Chem Commun(Camb),2015,51(13):2 544-2 546.
[15]
Afriansyah A,Hamid AR,Mochtar CA,et al.Targeted therapy for metastatic renal cell carcinoma[J].Acta Med Indones,2016,48(4):335-347.
[16]
Tornberg SV,Nisen H,VisapH,et al.Outcome of surgery for patients with renal cell carcinoma and tumour thrombus in the era of modern targeted therapy[J].Scand J Urol,2016,50(5):380-386.
[17]
Dawson G.Quantum dots and potential therapy for Krabbe’s disease[J].J Neurosci Res,2016,94(11):1 293-1 303.
